ROCKWELL MEDICAL, INC.
RMTINext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for RMTI. That does not mean none is planned.
Get an email about RMTI's next catalysts
Track ROCKWELL MEDICAL (RMTI) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
RMTI Earnings Report
EPS Est: $-0.13 | FQ end Sep/2026 | Call: bmo
Market Overview
Stock performance and key metrics
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
WebsiteSoluble Ferric Pyrophosphate (SFP)
Renal Failure Chronic Requiring Hemodialysis
SFP
End Stage Renal Disease
Erythrocyte Stimulating Agent (ESA)
End Stage Renal Disease
Soluble Ferric Pyrophosphate in liquid bicarbonate
End Stage Renal Disease
Triferic
End Stage Renal Disease
Intravenous (IV) Iron
End Stage Renal Disease
Soluble Ferric Pyrophosphate
Kidney Failure
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Soluble Ferric Pyrophosphate (SFP) | Phase 3 | Renal Failure Chronic Requiring Hemodialysis | - | - |
SFP | Phase 3 | End Stage Renal Disease | - | - |
Erythrocyte Stimulating Agent (ESA) | Phase 2 | End Stage Renal Disease | - | - |
Soluble Ferric Pyrophosphate in liquid bicarbonate | Phase 2 | End Stage Renal Disease | - | - |
Triferic | Phase 2 | End Stage Renal Disease | - | - |
Intravenous (IV) Iron | Phase 2 | End Stage Renal Disease | - | - |
Soluble Ferric Pyrophosphate | Phase 2 | Kidney Failure | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in ROCKWELL MEDICAL, INC.'s drug pipeline?→
CatalystAlert tracks 7 drug candidates in ROCKWELL MEDICAL, INC.'s (RMTI) pipeline across Phase 3, Phase 2. Its lead program is SFP (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is ROCKWELL MEDICAL, INC.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for ROCKWELL MEDICAL, INC. (RMTI) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track RMTI biotech catalysts?→
Add RMTI to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ROCKWELL MEDICAL, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.